This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Abl Bio Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Yonggyu Son
Introduction
Yonggyu Son is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific protein aggregates associated with various diseases.
Latest Patents
Yonggyu Son holds a patent for "Anti-alpha-synuclein antibodies and uses thereof." This patent discloses anti α-Syn antibodies that preferentially recognize α-Syn aggregates. The antibodies bind to α-Syn aggregates with high affinity and specificity, inhibiting their accumulation or intercellular transfer. This innovation has potential applications in the detection, diagnosis, treatment, and prevention of diseases caused by the accumulation of α-Syn aggregates.
Career Highlights
Yonggyu Son is currently associated with Abl Bio Inc., a company focused on developing innovative biopharmaceuticals. His work at Abl Bio Inc. emphasizes the importance of targeted therapies in treating neurodegenerative diseases.
Collaborations
Yonggyu Son has collaborated with notable colleagues, including Jinhyung Ahn and Sungwon An. Their combined expertise contributes to the advancement of research in the field of antibody development.
Conclusion
Yonggyu Son's innovative work in developing anti-alpha-synuclein antibodies showcases his commitment to addressing critical health challenges. His contributions have the potential to significantly impact the diagnosis and treatment of diseases related to protein aggregation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile